| Year |
Citation |
Score |
| 2020 |
Mei M, Tsai NC, Mokhtari S, Malki MMA, Ali H, Salhotra A, Sandhu K, Khaled S, Smith E, Snyder D, Marcucci G, Forman SJ, Pullarkat V, Stein A, Aldoss I, et al. Long-term Outcomes of Allogeneic Hematopoietic Cell transplantation with Fludarabine and Melphalan Conditioning and Tacrolimus/Sirolimus as GVHD prophylaxis in Patients with Acute Lymphoblastic Leukemia. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 32416253 DOI: 10.1016/j.bbmt.2020.04.015 |
0.327 |
|
| 2020 |
Salhotra A, Yang D, Mokhtari S, Malki MMA, Ali H, Sandhu KS, Aribi A, Khaled S, Mei M, Budde E, Snyder D, Cao T, Spielberger R, Marcucci G, Pullarkat V, et al. Outcomes of Allogeneic Hematopoietic Cell Transplantation after Salvage-Therapy with Blinatumomab in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 32035275 DOI: 10.1016/j.bbmt.2020.01.029 |
0.303 |
|
| 2020 |
Al Malki MM, Tsai N, Palmer J, Mokhtari S, Cao T, Ali H, Salhotra A, Arslan S, Aldoss I, Karras N, Ali HM, Ali H, Stein AS, Snyder DS, Marcucci G, et al. Efficacy of Post-Transplant Cyclophosphamide As Graft-Versus-Host Disease Prophylaxis after Peripheral Blood Stem Cell HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation; A Prospective Pilot Trial Blood. 136: 49-50. DOI: 10.1182/blood-2020-142807 |
0.314 |
|
| 2020 |
Ngo D, Mac S, Yang D, Mokhtari S, Chen J, Ali H, Arslan S, Salhotra A, Cao T, Karras N, Aldoss I, Koller P, Artz AS, Aribi A, Sandhu KS, ... ... Snyder DS, et al. Hemorrhagic Cystitis in Patients Undergoing Allogeneic Hematopoietic Cell Transplant with Post Transplant Cyclophosphamide As GvHD Prophylaxis Blood. 136: 21-22. DOI: 10.1182/blood-2020-139993 |
0.342 |
|
| 2019 |
DeFilipp Z, Ancheta R, Liu Y, Hu ZH, Gale RP, Snyder D, Schouten HC, Kalaycio M, Hildebrandt GC, Ustun C, Daly A, Ganguly S, Inamoto Y, Litzow M, Szer J, et al. Maintenance tyrosine kinase inhibitors following allo-HCT for chronic myeloid leukemia: A CIBMTR Study. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 31669399 DOI: 10.1016/j.bbmt.2019.10.017 |
0.332 |
|
| 2019 |
Salhotra A, Hui S, Yang D, Mokhtari S, Mei M, Al Malki MM, Aldoss I, Ali H, Sandhu KS, Aribi A, Khaled S, Dandapani S, Peng K, Teh JB, Murata-Collins J, ... ... Snyder D, et al. Long term outcomes of patients with Acute Myeloid Leukemia treated with myeloablative FTBI based conditioning with Tacrolimus and sirolimus based GVHD prophylaxis regimen: 6 year follow up from Single Center. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 31536825 DOI: 10.1016/J.Bbmt.2019.09.017 |
0.328 |
|
| 2019 |
Mei M, Gupta R, O'Donnell M, Al Malki MM, Aldoss I, Ali H, Farol L, Snyder D, Forman SJ, Nakamura R, Khaled S. Post-allogeneic eculizumab as prophylaxis against hemolysis and thrombosis for patients with hematologic disorders associated with PNH clones. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 30708188 DOI: 10.1016/j.bbmt.2019.01.025 |
0.317 |
|
| 2019 |
Yao JM, Yang D, Mokhtari S, Salhotra A, Ali H, Arslan S, Otoukesh S, Aldoss I, Sandhu KS, Stein A, Snyder D, Pullarkat VA, Marcucci G, Forman SJ, Nakamura R, et al. Optimization of Tacrolimus Serum Levels When Combined with Post-Transplant Cyclophosphamide As Graft-Versus-Host Disease Prophylaxis after Hematopoietic Cell Transplantation: Outcome Data Analysis Blood. 134: 4518-4518. DOI: 10.1182/blood-2019-129221 |
0.311 |
|
| 2019 |
Ali H, Snyder D, Stiller T, Synold T, Mokhtari S, Palmer J, Salhotra A, Pullarkat VA, Cai J, Forman SJ, Mei M, Nakamura R. Peri-Transplant Administration of Ruxolitinib Is Safe and Feasible in Patients with Myelofibrosis: Primary Results of a Pilot Open-Label Study of Ruxolitinib Administration in Combination with Reduced Intensity Conditioning Blood. 134: 669-669. DOI: 10.1182/BLOOD-2019-127445 |
0.338 |
|
| 2019 |
Sandhu KS, Aldoss I, Yang D, Mokhtari S, Mei M, Aribi A, Ali H, Malki MMA, Salhotra A, Khaled SK, Budde LE, Sun W, O'Donnell M, Snyder DS, Forman SJ, et al. A Retrospective Study of Venetoclax-Based Salvage Regimen As a Bridge to Allogeneic Hematopoietic Cell Transplantation (HCT) in High-Risk Acute Myeloid Leukemia (AML) Patients Biology of Blood and Marrow Transplantation. 25: S102-S103. DOI: 10.1016/J.BBMT.2018.12.372 |
0.325 |
|
| 2019 |
Salhotra A, Yang D, Mokhtari S, Mei M, Aribi A, Ali H, Al Malki MM, Sandhu KS, Khaled SK, Budde LE, O'Donnell M, Snyder DS, Forman SJ, Marcucci G, Pullarkat V, et al. A Retrospective Study of Blinatumomab Based Salvage Regimen As a Bridge to Allogeneic Hematopoietic Cell Transplantation (HCT) for Patients with Relapsed and Refractory ALL Biology of Blood and Marrow Transplantation. 25: S101-S102. DOI: 10.1016/J.BBMT.2018.12.371 |
0.327 |
|
| 2018 |
Al Malki MM, Nathwani N, Yang D, Armenian S, Dadwal S, Salman J, Mokhtari S, Cao T, Sandhu K, Rouse M, Mei M, Ali H, Parker P, Alvarnas J, Smith E, ... ... Snyder D, et al. Melphalan-Based Reduced Intensity Conditioning is Associated with Favorable Disease Control and Acceptable Toxicities in Patients Older Than 70 with Hematologic Malignancies Undergoing Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 29753158 DOI: 10.1016/j.bbmt.2018.04.029 |
0.336 |
|
| 2018 |
Gupta R, Aldoss I, Yang D, Mokhtari S, Khaled SK, Al Malki M, Salhotra A, Ali H, Aribi A, Cao T, Palmer J, O'Donnell M, Nademanee AP, Parker P, Forman SJ, ... Snyder DS, et al. Clinical Outcomes of MDS Patients Who Were Allogeneic Hematopoietic Stem Cell Transplant Candidates but Did Not Proceed with Transplantation Blood. 132: 2181-2181. DOI: 10.1182/blood-2018-99-115467 |
0.325 |
|
| 2018 |
Al Malki M, Dadwal S, Yang D, Mokhtari S, Cao T, Gendzekhadze K, Snyder DS, Ali H, Aldoss I, Salhotra A, Marcucci G, Karanes C, Parker P, Nademanee AP, Diamond D, et al. Incidence and Risk Factors of CMV Reactivation after Haploidentical Hematopoietic Cell Transplantation Using High-Dose Post-Transplant Cyclophosphamide - Possible Role of Donor KIR Genotypes Blood. 132: 3416-3416. DOI: 10.1182/BLOOD-2018-99-113514 |
0.326 |
|
| 2017 |
Stein A, Palmer J, Tsai NC, Al Malki MM, Aldoss I, Ali H, Aribi A, Farol L, Karanes C, Khaled S, Liu A, O'Donnell M, Parker P, Pawlowska A, Pullarkat V, ... ... Snyder D, et al. Phase I Trial of Total Marrow and Lymphoid Irradiation Transplant Conditioning in Patients with Relapsed/Refractory Acute Leukemia. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 28087456 DOI: 10.1016/j.bbmt.2017.01.067 |
0.315 |
|
| 2016 |
Al Malki MM, Aldoss I, Stiller T, Nakamura R, Snyder DS, Forman SJ, Pullarkat V. Outcome of Second Allogeneic Hematopoietic Cell Transplantation in Patients With Acute Lymphoblastic Leukemia. Clinical Lymphoma, Myeloma & Leukemia. PMID 27394652 DOI: 10.1016/j.clml.2016.06.005 |
0.315 |
|
| 2015 |
Stein AS, Wong JYC, Palmer J, O'Donnell M, Snyder DS, Tsai N, Parker PM, Spielberger R, Farol L, Marcucci G, Radany E, Schultheiss T, Liu A, Aldoss I, Forman SJ. A Phase I Trial of Total Marrow and Lymphoid Irradiation (TMLI)-Based Transplant Conditioning in Patients (Pts) with Relapsed/Refractory Acute Leukemia Blood. 126: 735-735. DOI: 10.1182/BLOOD.V126.23.735.735 |
0.307 |
|
| 2014 |
Huang Q, Reddi D, Chu P, Snyder DS, Weisenburger DD. Clinical and pathologic analysis of extramedullary tumors after hematopoietic stem cell transplantation. Human Pathology. 45: 2404-10. PMID 25294373 DOI: 10.1016/j.humpath.2014.07.022 |
0.315 |
|
| 2014 |
Wong J, Stein A, Palmer J, Liu A, O'Donnell M, Schultheiss T, Radany E, Snyder D, Tsai N, Parker P, Farol L, Spielberger R, Sahebi F, Murata-Collins J, Senitzer D, et al. Phase 1 Dose Escalation Trial of Total Marrow and Lymphoid Irradiation (TMLI) Using Helical Tomotherapy Combined With Etoposide (VP16) and Cyclophosphamide (CY) in Patients With Refractory Acute Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation (alloHCT) International Journal of Radiation Oncology*Biology*Physics. 90: S681. DOI: 10.1016/J.IJROBP.2014.05.2002 |
0.314 |
|
| 2013 |
Khaled SK, Palmer J, Stiller T, Senitzer D, Maegawa R, Rodriguez R, Parker PM, Nademanee A, Cai JL, Snyder DS, Karanes C, Osorio E, Thomas SH, Forman SJ, Nakamura R. A phase II study of sirolimus, tacrolimus and rabbit anti-thymocyte globulin as GVHD prophylaxis after unrelated-donor PBSC transplant. Bone Marrow Transplantation. 48: 278-83. PMID 23000644 DOI: 10.1038/bmt.2012.175 |
0.33 |
|
| 2012 |
Nakamura R, Palmer JM, O'Donnell MR, Stiller T, Thomas SH, Chao J, Alvarnas J, Parker PM, Pullarkat V, Maegawa R, Stein AS, Snyder DS, Bhatia R, Chang K, Wang S, et al. Reduced intensity allogeneic hematopoietic stem cell transplantation for MDS using tacrolimus/sirolimus-based GVHD prophylaxis. Leukemia Research. 36: 1152-6. PMID 22677229 DOI: 10.1016/j.leukres.2012.04.022 |
0.325 |
|
| 2012 |
Kirschbaum MH, Stein AS, Popplewell L, Delioukina M, Chen R, Nakamura R, Snyder D, Conrad J, Lacey SF, Frankel P, Dagis A, Nademanee A, Forman SJ. A phase I study in adults of clofarabine combined with high-dose melphalan as reduced-intensity conditioning for allogeneic transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 18: 432-40. PMID 21801703 DOI: 10.1016/j.bbmt.2011.07.017 |
0.327 |
|
| 2011 |
Stein AS, O'Donnell MR, Synold TW, Dagis AC, Tsirunyan A, Nademanee AP, Parker PM, Pullarkat VA, Snyder DS, Spielberger RT, Wong JY, Alvarnas JC, Thomas SH, Forman SJ. Phase-2 trial of an intensified conditioning regimen for allogeneic hematopoietic cell transplant for poor-risk leukemia. Bone Marrow Transplantation. 46: 1256-62. PMID 21151180 DOI: 10.1038/bmt.2010.295 |
0.339 |
|
| 2010 |
Rodriguez R, Nakamura R, Palmer JM, Parker P, Shayani S, Nademanee A, Snyder D, Pullarkat V, Kogut N, Rosenthal J, Smith E, Karanes C, O'Donnell M, Krishnan AY, Senitzer D, et al. A phase II pilot study of tacrolimus/sirolimus GVHD prophylaxis for sibling donor hematopoietic stem cell transplantation using 3 conditioning regimens. Blood. 115: 1098-105. PMID 19965688 DOI: 10.1182/blood-2009-03-207563 |
0.341 |
|
| 2010 |
Snyder DS, Palmer J, Gaal K, Stein AS, Pullarkat V, Sahebi F, Vora N, Nakamura R, Forman SJ. Improved outcomes using tacrolimus/sirolimus for graft-versus-host disease prophylaxis with a reduced-intensity conditioning regimen for allogeneic hematopoietic cell transplant as treatment of myelofibrosis. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 16: 281-6. PMID 19786111 DOI: 10.1016/j.bbmt.2009.09.020 |
0.349 |
|
| 2010 |
Kirschbaum M, Stein AS, Frankel P, Popplewell L, Chen Rw, Delioukina ML, Nakamura R, Snyder DS, Slape C, Ruel C, Conrad J, Nademanee A, Forman S. Final Report of a Phase I Study of Clofarabine Plus High Dose Melphalan as a Conditioning Regimen for Allogeneic Transplantation Blood. 116: 528-528. DOI: 10.1182/BLOOD.V116.21.528.528 |
0.327 |
|
| 2009 |
Stein AS, Palmer JM, O'Donnell MR, Kogut NM, Spielberger RT, Slovak ML, Tsai NC, Senitzer D, Snyder DS, Thomas SH, Forman SJ. Reduced-intensity conditioning followed by peripheral blood stem cell transplantation for adult patients with high-risk acute lymphoblastic leukemia. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 15: 1407-14. PMID 19822300 DOI: 10.1016/j.bbmt.2009.07.003 |
0.346 |
|
| 2009 |
Nakamura R, Palmer J, Parker P, Stein A, Stiller T, Pullarkat V, Snyder DS, Cai J, Wang S, Senitzer D, Chang KL, Bhatia R, Forman SJ, O'Donnell M. Improved Outcome After Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation (RI-HCT) for Myelodysplastic Syndrome (MDS) Using Tacrolimus/Sirolimus-Based Gvhd Prophylaxis. Blood. 114: 2771-2771. DOI: 10.1182/BLOOD.V114.22.2771.2771 |
0.307 |
|
| 2008 |
Openshaw H, Ressler JA, Snyder DS. Lumbar puncture and subdural hygroma and hematomas in hematopoietic cell transplant patients. Bone Marrow Transplantation. 41: 791-5. PMID 18246118 DOI: 10.1038/sj.bmt.1705971 |
0.301 |
|
| 2008 |
Khuu T, Shayani S, Palmer J, Rodriguez R, Parker PM, Snyder DS, Pullarkat V, Rosenthal J, Nademanee AP, Senitzer D, Nakamura R, Forman SJ. Thrombotic Microangiopathy with Tacrolimus/Sirolimus-Based GVHD Prophylaxis Regimen in Patients Undergoing Hematopoietic Stem Cell Transplant from a Matched Unrelated Donor Blood. 112: 797-797. DOI: 10.1182/BLOOD.V112.11.797.797 |
0.35 |
|
| 2008 |
Rosenthal J, Wong JY, Somlo G, Snyder D, O’Donnell M, Stein A, Nademanee A, Delioukina M, Popplewell L, Parker P, Spielberger R, Sahebi F, Karanes C, Hitt D, Naeem H, et al. Adding Total Marrow and Lymph Node Irradiation (TMLI) Using Helical Tomotherapy to Reduced Intensity Conditioning (RIC) Regimen of Fludarabine (FLU) and Melphalan (MEL) in Patients (pts) with Advanced Hematological Malignancies. Blood. 112: 3271-3271. DOI: 10.1182/BLOOD.V112.11.3271.3271 |
0.302 |
|
| 2007 |
Huang Q, Wu Y, Snyder DS, Chang KL, Slovak ML, Gaal KK, Palmer JM, Weiss LM. Clinical and pathologic analysis of 16 cases of relapsed chronic myeloid leukemia after stem cell transplantation. American Journal of Clinical Pathology. 128: 565-70. PMID 17875506 DOI: 10.1309/ECDWCRLG889K1GGD |
0.31 |
|
| 2007 |
Oehler VG, Gooley T, Snyder DS, Johnston L, Lin A, Cummings CC, Chu S, Bhatia R, Forman SJ, Negrin RS, Appelbaum FR, Radich JP. The effects of imatinib mesylate treatment before allogeneic transplantation for chronic myeloid leukemia. Blood. 109: 1782-9. PMID 17062727 DOI: 10.1182/blood-2006-06-031682 |
0.336 |
|
| 2006 |
Snyder DS, Palmer J, Stein AS, Pullarkat V, Sahebi F, Cohen S, Vora N, Gaal K, Nakamura R, Forman SJ. Allogeneic hematopoietic cell transplantation following reduced intensity conditioning for treatment of myelofibrosis. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 12: 1161-8. PMID 17085309 DOI: 10.1016/j.bbmt.2006.06.014 |
0.356 |
|
| 2006 |
Rodriguez R, Palmer J, Nakamura R, Parker PM, Nademanee AP, Snyder DS, Pullarkat V, Zain JM, Spielberger R, Senitzer D, Forman SJ. Tacrolimus and Sirolimus as GVHD Prophylaxis for HLA-MRD Allogeneic HCT Conditioned with 3 Regimens: Toxicity and Efficacy in 70 Patients. Blood. 108: 2867-2867. DOI: 10.1182/blood.v108.11.2867.2867 |
0.336 |
|
| 2006 |
Nakamura R, Rodriguez R, Nademanee A, Palmer J, Senitzer D, Snyder D, Zain J, Pullarkat V, Forman SJ, Parker PM. The Use of Sirolimus Combined with Tacrolimus and Low-Dose Methotrexate Is Effective in Preventing Graft-Versus-Host Disease after Unrelated Donor Hematopoietic Stem Cell Transplantation. Blood. 108: 2866-2866. DOI: 10.1182/BLOOD.V108.11.2866.2866 |
0.33 |
|
| 2005 |
Oehler VG, Radich JP, Storer B, Blume KG, Chauncey T, Clift R, Snyder DS, Forman SJ, Flowers ME, Martin P, Guthrie KA, Negrin RS, Appelbaum FR, Bensinger W. Randomized trial of allogeneic related bone marrow transplantation versus peripheral blood stem cell transplantation for chronic myeloid leukemia. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 11: 85-92. PMID 15682068 DOI: 10.1016/J.Bbmt.2004.09.010 |
0.341 |
|
| 2005 |
Carpenter PA, Snyder DS, Flowers ME, Sanders JE, Martin PJ, Radich JP. A Pilot Study Evaluating the Safety and Efficacy of Imatinib Given Early after Transplant for High-Risk Philadelphia Chromosome-Postive Leukemias. Blood. 106: 1095-1095. DOI: 10.1182/BLOOD.V106.11.1095.1095 |
0.3 |
|
| 2004 |
Rodriguez R, Parker P, Nademanee A, Smith D, O'Donnell MR, Stein A, Snyder DS, Fung HC, Krishnan AY, Popplewell L, Cohen S, Somlo G, Angelopoulou M, Al-Kadhimi Z, Falk PM, et al. Cyclosporine and mycophenolate mofetil prophylaxis with fludarabine and melphalan conditioning for unrelated donor transplantation: a prospective study of 22 patients with hematologic malignancies. Bone Marrow Transplantation. 33: 1123-9. PMID 15064696 DOI: 10.1038/sj.bmt.1704493 |
0.346 |
|
| 2004 |
Oehler VG, Gooley T, Snyder DS, Forman SJ, Radich JP. A Retrospective Study of Patients Treated with Imatinib Mesylate Prior to Allogeneic Hematopoietic Stem Cell Transplant. Blood. 104: 2752-2752. DOI: 10.1182/blood.v104.11.2752.2752 |
0.337 |
|
| 2003 |
Fung HC, Stein A, Slovak Ml, O'donnell MR, Snyder DS, Cohen S, Smith D, Krishnan A, Spielberger R, Bhatia R, Bhatia S, Falk P, Molina A, Nademanee A, Parker P, et al. A long-term follow-up report on allogeneic stem cell transplantation for patients with primary refractory acute myelogenous leukemia: impact of cytogenetic characteristics on transplantation outcome. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 9: 766-71. PMID 14677116 DOI: 10.1016/j.bbmt.2003.08.004 |
0.334 |
|
| 2003 |
Fung HC, Cohen S, Rodriguez R, Smith D, Krishnan A, Somlo G, Sahebi F, Senitzer D, O'Donnell MR, Stein A, Snyder DS, Spielberger R, Bhatia R, Falk P, Molina A, et al. Reduced-intensity allogeneic stem cell transplantation for patients whose prior autologous stem cell transplantation for hematologic malignancy failed. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 9: 649-56. PMID 14569561 DOI: 10.1016/S1083-8791(03)00241-6 |
0.366 |
|
| 2003 |
Stein AS, O'Donnell MR, Slovak ML, Snyder DS, Nademanee AP, Parker P, Molina A, Somlo G, Fung HC, Krishnan A, Rodriguez R, Spielberger RT, Wang S, Dagis A, Vora N, et al. Interleukin-2 after autologous stem-cell transplantation for adult patients with acute myeloid leukemia in first complete remission. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 21: 615-23. PMID 12586797 DOI: 10.1200/JCO.2003.12.125 |
0.302 |
|
| 2002 |
Weisdorf DJ, Anasetti C, Antin JH, Kernan NA, Kollman C, Snyder D, Petersdorf E, Nelson G, McGlave P. Allogeneic bone marrow transplantation for chronic myelogenous leukemia: comparative analysis of unrelated versus matched sibling donor transplantation. Blood. 99: 1971-7. PMID 11877268 DOI: 10.1182/BLOOD.V99.6.1971 |
0.307 |
|
| 2000 |
Nademanee A, Molina A, Dagis A, Snyder DS, O'Donnell MR, Parker P, Stein A, Smith E, Planas I, Kashyap A, Spielberger R, Fung H, Krishnan A, Bhatia R, Wong KK, et al. Autologous stem-cell transplantation for poor-risk and relapsed intermediate- and high-grade non-Hodgkin's lymphoma. Clinical Lymphoma. 1: 46-54. PMID 11707813 |
0.336 |
|
| 2000 |
Snyder DS. Allogeneic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 6: 597-603. PMID 11128809 |
0.316 |
|
| 1999 |
Snyder DS, Nademanee AP, O'Donnell MR, Parker PM, Stein AS, Margolin K, Somlo G, Molina A, Spielberger R, Kashyap A, Fung H, Slovak ML, Dagis A, Negrin RS, Amylon MD, et al. Long-term follow-up of 23 patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with allogeneic bone marrow transplant in first complete remission. Leukemia. 13: 2053-8. PMID 10602428 |
0.358 |
|
| 1999 |
Nademanee A, Molina A, Fung H, Stein A, Parker P, Planas I, O'Donnell MR, Snyder DS, Kashyap A, Spielberger R, Bhatia R, Krishnan A, Sniecinski I, Vora N, Slovak M, et al. High-dose chemo/radiotherapy and autologous bone marrow or stem cell transplantation for poor-risk advanced-stage Hodgkin's disease during first partial or complete remission. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 5: 292-8. PMID 10534059 |
0.306 |
|
| 1999 |
Ross M, Schmidt GM, Niland JC, Amylon MD, Dagis AC, Long GD, Nademanee AP, Negrin RS, O'Donnell MR, Parker PM, Smith EP, Snyder DS, Stein AS, Wong RM, Forman SJ, et al. Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prevention of acute graft-vs.-host disease: effect on chronic graft-vs.-host disease and long-term survival. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 5: 285-91. PMID 10534058 |
0.317 |
|
| 1997 |
Long GD, Amylon MD, Stockerl-Goldstein KE, Negrin RS, Chao NJ, Hu WW, Nademanee AP, Snyder DS, Hoppe RT, Vora N, Wong R, Niland J, Reichardt VL, Forman SJ, Blume KG. Fractionated total-body irradiation, etoposide, and cyclophosphamide followed by allogeneic bone marrow transplantation for patients with high-risk or advanced-stage hematological malignancies. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 3: 324-30. PMID 9502300 |
0.359 |
|
| 1997 |
Nademanee A, Molina A, O'Donnell MR, Dagis A, Snyder DS, Parker P, Stein A, Smith E, Planás I, Kashyap A, Spielberger R, Fung H, Wong KK, Somlo G, Margolin K, et al. Results of high-dose therapy and autologous bone marrow/stem cell transplantation during remission in poor-risk intermediate- and high-grade lymphoma: international index high and high-intermediate risk group. Blood. 90: 3844-52. PMID 9354650 |
0.318 |
|
| 1996 |
Chao NJ, Parker PM, Niland JC, Wong RM, Dagis A, Long GD, Nademanee AP, Negrin RS, Snyder DS, Hu WW, Gould KA, Tierney DK, Zwingenberger K, Forman SJ, Blume KG. Paradoxical effect of thalidomide prophylaxis on chronic graft-vs.-host disease. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 2: 86-92. PMID 9118303 |
0.308 |
|
| 1995 |
Nademanee A, O'Donnell MR, Snyder DS, Schmidt GM, Parker PM, Stein AS, Smith EP, Molina A, Stepan DE, Somlo G. High-dose chemotherapy with or without total body irradiation followed by autologous bone marrow and/or peripheral blood stem cell transplantation for patients with relapsed and refractory Hodgkin's disease: results in 85 patients with analysis of prognostic factors. Blood. 85: 1381-90. PMID 7858268 |
0.36 |
|
| 1995 |
Nademanee A, Schmidt GM, Parker P, Dagis AC, Stein A, Snyder DS, O'Donnell M, Smith EP, Stepan DE, Molina A. The outcome of matched unrelated donor bone marrow transplantation in patients with hematologic malignancies using molecular typing for donor selection and graft-versus-host disease prophylaxis regimen of cyclosporine, methotrexate, and prednisone. Blood. 86: 1228-34. PMID 7620176 |
0.352 |
|
| 1994 |
Snyder DS, Negrin RS, O'Donnell MR, Chao NJ, Amylon MD, Long GD, Nademanee AP, Stein AS, Parker PM, Smith EP. Fractionated total-body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 94 patients with chronic myelogenous leukemia in chronic phase. Blood. 84: 1672-9. PMID 8068956 |
0.346 |
|
| 1993 |
Snyder DS, Chao NJ, Amylon MD, Taguchi J, Long GD, Negrin RS, Nademanee AP, O'Donnell MR, Schmidt GM, Stein AS. Fractionated total body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 99 patients with acute leukemia in first complete remission. Blood. 82: 2920-8. PMID 8219241 |
0.331 |
|
| 1992 |
Nademanee A, Schmidt GM, O'Donnell MR, Snyder DS, Parker PA, Stein A, Smith E, Lipsett JA, Sniecinski I, Margolin K. High-dose chemoradiotherapy followed by autologous bone marrow transplantation as consolidation therapy during first complete remission in adult patients with poor-risk aggressive lymphoma: a pilot study. Blood. 80: 1130-4. PMID 1515634 |
0.333 |
|
| 1991 |
Chao NJ, Forman SJ, Schmidt GM, Snyder DS, Amylon MD, Konrad PN, Nademanee AP, O'Donnell MR, Parker PM, Stein AS. Allogeneic bone marrow transplantation for high-risk acute lymphoblastic leukemia during first complete remission. Blood. 78: 1923-7. PMID 1912575 |
0.332 |
|
| 1991 |
Forman SJ, Schmidt GM, Nademanee AP, Amylon MD, Chao NJ, Fahey JL, Konrad PN, Margolin KA, Niland JC, O'Donnell MR, Parker PM, Smith EP, Snyder DS, Somlo G, Stein AS, et al. Allogeneic bone marrow transplantation as therapy for primary induction failure for patients with acute leukemia Journal of Clinical Oncology. 9: 1570-1574. PMID 1875218 DOI: 10.1200/JCO.1991.9.9.1570 |
0.324 |
|
| 1991 |
Snyder DS, Rossi JJ, Wang JL, Sniecinski IJ, Slovak ML, Wallace RB, Forman SJ. Persistence of bcr-able gene expression following bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Transplantation. 51: 1033-40. PMID 1674385 DOI: 10.1097/00007890-199105000-00020 |
0.303 |
|
| 1990 |
Snyder DS, McGlave PB. Treatment of chronic myelogenous leukemia with bone marrow transplantation. Hematology/Oncology Clinics of North America. 4: 535-57. PMID 2193013 |
0.357 |
|
| 1988 |
Snyder DS, Findley DO, Forman SJ, Nademanee AP, O'Donnell MR, Schmidt GM, Bierman PJ, Fahey JL, Krance RA, Sniecinski IJ. Fractionated total body irradiation and high dose cyclophosphamide: a preparative regimen for bone marrow transplantation for patients with hematologic malignancies in first complete remission. Blut. 57: 7-13. PMID 3291991 DOI: 10.1007/BF00320628 |
0.339 |
|
| 1987 |
Forman SJ, Krance RA, O'Donnell MR, Nademanee AP, Snyder DS, Fahey JL, Schmidt GM, Zaia JA, Lipsett JA, Findley DO. Bone marrow transplantation for acute nonlymphoblastic leukemia during first complete remission. An analysis of prognostic factors. Transplantation. 43: 650-3. PMID 3554657 DOI: 10.1097/00007890-198705000-00009 |
0.314 |
|
| 1987 |
Blume KG, Forman SJ, O'Donnell MR, Doroshow JH, Krance RA, Nademanee AP, Snyder DS, Schmidt GM, Fahey JL, Metter GE. Total body irradiation and high-dose etoposide: a new preparatory regimen for bone marrow transplantation in patients with advanced hematologic malignancies. Blood. 69: 1015-20. PMID 3548841 |
0.314 |
|
| 1987 |
Blume KG, Forman SJ, Snyder DS, Nademanee AP, O'Donnell MR, Fahey JL, Krance RA, Sniecinski IJ, Stock AD, Findley DO. Allogeneic bone marrow transplantation for acute lymphoblastic leukemia during first complete remission. Transplantation. 43: 389-92. PMID 3547796 DOI: 10.1097/00007890-198703000-00014 |
0.359 |
|
| 1987 |
O'Donnell MR, Nademanee AP, Snyder DS, Schmidt GM, Parker PM, Bierman PJ, Fahey JL, Stein AS, Krance RA, Stock AD. Bone marrow transplantation for myelodysplastic and myeloproliferative syndromes. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 5: 1822-6. PMID 3316515 DOI: 10.1200/JCO.1987.5.11.1822 |
0.329 |
|
| 1987 |
Nademanee AP, Forman SJ, Schmidt GM, Bierman PJ, Snyder DS, O'Donnell MR, Lipsett JA, Blume KG. Allogeneic bone marrow transplantation for high risk non-Hodgkin's lymphoma during first complete remission. Blut. 55: 11-8. PMID 3300816 DOI: 10.1007/BF00319636 |
0.326 |
|
| 1987 |
Forman S, O'Donnell M, Nademanee A, Snyder D, Bierman P, Schmidt G, Fahey J, Stein A, Parker P, Blume K. Bone marrow transplantation for patients with Philadelphia chromosome- positive acute lymphoblastic leukemia Blood. 70: 587-588. DOI: 10.1182/BLOOD.V70.2.587.BLOODJOURNAL702587 |
0.32 |
|
| 1987 |
Forman S, O'Donnell M, Nademanee A, Snyder D, Bierman P, Schmidt G, Fahey J, Stein A, Parker P, Blume K. Bone marrow transplantation for patients with Philadelphia chromosome- positive acute lymphoblastic leukemia Blood. 70: 587-588. DOI: 10.1182/blood.v70.2.587.587 |
0.32 |
|
| 1987 |
Blume K, Forman S, O'Donnell M, Doroshow J, Krance R, Nademanee A, Snyder D, Schmidt G, Fahey J, Metter G. Total body irradiation and high-dose etoposide: a new preparatory regimen for bone marrow transplantation in patients with advanced hematologic malignancies [published erratum appears in Blood 1987 Jun;69(6):1789] Blood. 69: 1015-1020. DOI: 10.1182/BLOOD.V69.4.1015.BLOODJOURNAL6941015 |
0.316 |
|
| 1987 |
Blume K, Forman S, O'Donnell M, Doroshow J, Krance R, Nademanee A, Snyder D, Schmidt G, Fahey J, Metter G. Total body irradiation and high-dose etoposide: a new preparatory regimen for bone marrow transplantation in patients with advanced hematologic malignancies [published erratum appears in Blood 1987 Jun;69(6):1789] Blood. 69: 1015-1020. DOI: 10.1182/blood.v69.4.1015.1015 |
0.316 |
|
| 1986 |
Blume KG, Forman SJ, Nademanee AP, O'Donnell MR, Snyder DS, Fahey JL, Sniecinski IJ, Findley DO, Lipsett JA, Zaia JA. Bone marrow transplantation for hematologic malignancies in patients aged 30 years or older. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 4: 1489-92. PMID 3531423 DOI: 10.1200/JCO.1986.4.10.1489 |
0.339 |
|
| Show low-probability matches. |